Engineering and Development

Accounting and Finance

Chief Financial Officer

CNS disorder biotech MapLight Therapeutics sets terms for $251 million IPO

MapLight Therapeutics Announces Commencement of Initial Public Offering

Drug developer MapLight eyes $704.3 million valuation in US IPO

Biotech Share Of US Funding Hits Lowest Point In Crunchbase History

Director, Clinical Pharmacology & Pharmacometrics

MapLight Therapeutics is a clinical stage biotech company focused on drug discovery for central nervous system disorders. The Director will serve as Pharmacometrics Lead and Clinical Pharmacology Lead, shaping clinical strategy and applying scientific expertise in PK and PD to optimize dosing regimens for investigational drugs.

Sign up with Google

Sign in with Google